HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,355,000 | -50.7% | 126,942 | -63.5% | 0.03% | -50.0% |
| Q4 2018 | $6,804,000 | -20.1% | 348,227 | -19.9% | 0.06% | +30.4% |
| Q3 2018 | $8,514,000 | -10.7% | 434,832 | -24.5% | 0.05% | -6.1% |
| Q2 2018 | $9,534,000 | +64.8% | 575,715 | +41.3% | 0.05% | +40.0% |
| Q1 2018 | $5,786,000 | +355.2% | 407,438 | +368.1% | 0.04% | +400.0% |
| Q4 2017 | $1,271,000 | +80.5% | 87,049 | +56.7% | 0.01% | +40.0% |
| Q3 2017 | $704,000 | -91.5% | 55,556 | -92.1% | 0.01% | -92.5% |
| Q2 2017 | $8,331,000 | -31.1% | 701,855 | -14.2% | 0.07% | -33.7% |
| Q1 2017 | $12,090,000 | +155.9% | 818,015 | +180.2% | 0.10% | +146.3% |
| Q4 2016 | $4,724,000 | +98.6% | 291,939 | +122.4% | 0.04% | +86.4% |
| Q3 2016 | $2,379,000 | +167.3% | 131,241 | +142.9% | 0.02% | +175.0% |
| Q2 2016 | $890,000 | +156.5% | 54,027 | +157.7% | 0.01% | +166.7% |
| Q1 2016 | $347,000 | -85.2% | 20,967 | -80.6% | 0.00% | -87.5% |
| Q4 2015 | $2,343,000 | +482.8% | 108,116 | +432.6% | 0.02% | +500.0% |
| Q3 2015 | $402,000 | -95.4% | 20,300 | -93.9% | 0.00% | -96.6% |
| Q1 2015 | $8,673,000 | +3806.8% | 333,975 | +1841.7% | 0.12% | +3833.3% |
| Q4 2014 | $222,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 144,340 | $16,698 | 9.92% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 45,559 | $3,145 | 0.01% |